$BIMI
BIMI Holdings Inc. Stock $bimi

$bimi Overview Financials Valuation SEC Filings Company Website

2013 Q2 Form 10-Q Financial Statement

#000114420413045501 Filed on August 14, 2013

Income Statement

Concept	2013 Q2	2012 Q4	2012 Q2
Revenue	$1.475M	$3.020M	$3.303M
YoY Change	-55.33%	-37.47%	-32.41%
Cost Of Revenue	$1.044M	$2.410M	$2.793M
YoY Change	-62.6%	-21.75%	-25.8%
Gross Profit	$430.9K	$610.0K	$509.8K
YoY Change	-15.46%	-65.14%	-54.59%
Gross Profit Margin	29.21%	20.2%	15.43%
Selling, General & Admin	$257.4K	$520.0K	$280.2K
YoY Change	-8.11%	44.44%	-36.84%
% of Gross Profit	59.74%	85.25%	54.96%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$195.1K	$260.0K	$195.9K
YoY Change	-0.41%	73.33%	50.86%
% of Gross Profit	45.28%	42.62%	38.44%
Operating Expenses	$257.4K	$520.0K	$280.2K
YoY Change	-8.11%	44.44%	-36.84%
Operating Profit	$173.5K	$90.00K	$229.6K
YoY Change	-24.44%	-93.53%	-66.18%
Interest Expense	$116.0K	-$40.00K	$183.4K
YoY Change	-36.76%	-50.0%	121.96%
% of Operating Profit	66.85%	-44.44%	79.89%
Other Income/Expense, Net	-$107.5K		-$177.0K
YoY Change	-39.3%		115.75%
Pretax Income	$66.02K	$60.00K	$52.56K
YoY Change	25.6%	-95.42%	-91.19%
Income Tax	$14.00K	-$10.00K	$33.71K
% Of Pretax Income	21.21%	-16.67%	64.13%
Net Earnings	$52.02K	$70.00K	$18.85K
YoY Change	175.89%	-94.07%	-96.22%
Net Earnings / Revenue	3.53%	2.32%	0.57%
Basic Earnings Per Share	$0.01		$0.00
Diluted Earnings Per Share	$0.01	$12.84K	$0.00
COMMON SHARES
Basic Shares Outstanding	5.494M shares		5.327M shares
Diluted Shares Outstanding	5.459M shares		5.455M shares

Balance Sheet

Concept	2013 Q2	2012 Q4	2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$930.0K	$3.070M	$2.820M
YoY Change	-67.02%	32.33%	605.0%
Cash & Equivalents	$934.5K	$3.071M	$2.820M
Short-Term Investments
Other Short-Term Assets	$3.460M	$1.870M	$2.340M
YoY Change	47.86%	-39.68%	277.42%
Inventory	$2.643M	$1.206M	$876.8K
Prepaid Expenses		$106.3K
Receivables	$6.942M	$6.657M	$10.21M
Other Receivables	$0.00	$5.071K	$910.0K
Total Short-Term Assets	$14.82M	$13.69M	$17.14M
YoY Change	-13.54%	-21.11%	-10.43%
LONG-TERM ASSETS
Property, Plant & Equipment	$10.29M	$10.59M	$10.94M
YoY Change	-5.96%	-5.78%	-26.1%
Goodwill
YoY Change
Intangibles			$3.102M
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$30.11M	$29.14M	$26.75M
YoY Change	12.55%	10.12%	49.01%
TOTAL ASSETS
Total Short-Term Assets	$14.82M	$13.69M	$17.14M
Total Long-Term Assets	$30.11M	$29.14M	$26.75M
Total Assets	$44.94M	$42.83M	$43.90M
YoY Change	2.36%	-2.25%	18.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.050M	$1.380M	$2.410M
YoY Change	-14.94%	-48.51%	2.55%
Accrued Expenses			$350.0K
YoY Change			-22.22%
Deferred Revenue
YoY Change
Short-Term Debt	$8.338M	$6.016M	$5.803M
YoY Change	43.68%	-17.55%	26.44%
Long-Term Debt Due		$0.00	$960.0K
YoY Change		-100.0%	-17.24%
Total Short-Term Liabilities	$13.37M	$13.02M	$14.19M
YoY Change	-5.82%	-2.41%	51.31%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change		-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.37M	$13.02M	$14.19M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$13.37M	$13.02M	$14.19M
YoY Change	-5.82%	-8.96%	51.31%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$9.480M	$8.469M	$8.449M
YoY Change	12.21%	0.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$31.57M	$29.81M	$29.71M
YoY Change
Total Liabilities & Shareholders Equity	$44.94M	$42.83M	$43.90M
YoY Change	2.36%	-2.25%	18.36%

Cashflow Statement

Concept	2013 Q2	2012 Q4	2012 Q2
OPERATING ACTIVITIES
Net Income	$52.02K	$70.00K	$18.85K
YoY Change	175.89%	-94.07%	-96.22%
Depreciation, Depletion And Amortization	$195.1K	$260.0K	$195.9K
YoY Change	-0.41%	73.33%	50.86%
Cash From Operating Activities	$710.0K	$3.340M	-$1.050M
YoY Change	-167.62%		600.0%
INVESTING ACTIVITIES
Capital Expenditures	-$720.0K	-$2.750M	-$460.0K
YoY Change	56.52%	623.68%	-80.67%
Acquisitions
YoY Change
Other Investing Activities	$0.00		$0.00
YoY Change
Cash From Investing Activities	-$730.0K	-$2.750M	-$460.0K
YoY Change	58.7%	623.68%	-80.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-400.0K	-320.0K	0.000
YoY Change		-112.8%	-100.0%
NET CHANGE
Cash From Operating Activities	710.0K	3.340M	-1.050M
Cash From Investing Activities	-730.0K	-2.750M	-460.0K
Cash From Financing Activities	-400.0K	-320.0K	0.000
Net Change In Cash	-420.0K	270.0K	-1.510M
YoY Change	-72.19%	-87.26%	-43.66%
FREE CASH FLOW
Cash From Operating Activities	$710.0K	$3.340M	-$1.050M
Capital Expenditures	-$720.0K	-$2.750M	-$460.0K
Free Cash Flow	$1.430M	$6.090M	-$590.0K
YoY Change	-342.37%	1502.63%	-126.46%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
	dei	Document Period End Date DocumentPeriodEndDate	2013-06-30
	dei	Amendment Flag AmendmentFlag	false
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	509330	USD
	dei	Entity Registrant Name EntityRegistrantName	NF Energy Saving Corp
	dei	Entity Central Index Key EntityCentralIndexKey	0001213660
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2013Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2013Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5459147	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5326501	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5326501	shares
CY2013Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5459147	shares
	dei	Document Type DocumentType	10-Q
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3071367	USD
CY2013Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	2747164	USD
CY2012Q4	us-gaap	Retained Earnings Unappropriated RetainedEarningsUnappropriated	15512663	USD
	dei	Trading Symbol TradingSymbol	NFEC
CY2013Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5459147	shares
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	934541	USD
CY2013Q2	nfec	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	1051973	USD
CY2013Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	167	USD
CY2012Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	471679	USD
CY2013Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	8338451	USD
CY2012Q2	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	707650	USD
CY2013Q2	us-gaap	Operating Expenses OperatingExpenses	257449	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	498169	USD
CY2013Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1006004	USD
CY2012Q4	us-gaap	Contract Receivable Retainage Due One Year Or Less ContractReceivableRetainageDueOneYearOrLess	883421	USD
CY2012Q4	us-gaap	Inventory Net InventoryNet	1205560	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1083726	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	13693082	USD
CY2013Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	14456569	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3101142	USD
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	791628	USD
CY2013Q2	us-gaap	Interest Expense InterestExpense	115976	USD
CY2013Q2	us-gaap	Cost Of Services CostOfServices	38487	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	2735429	USD
CY2013Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	2045310	USD
CY2013Q2	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	1500000	USD
CY2013Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	431682	USD
CY2013Q2	us-gaap	Assets Assets	44936853	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10587181	USD
CY2012Q4	us-gaap	Assets Assets	42831702	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3071015	USD
CY2013Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	USD
CY2012Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	960000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13018352	USD
CY2012Q4	us-gaap	Liabilities Liabilities	13018352	USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	5326	USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	8463291	USD
CY2012Q4	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	2212951	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3619119	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	29813350	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	42831702	USD
CY2013Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	1420387	USD
CY2012Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2594974	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	2302350	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	3234736	USD
CY2013Q2	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	55029	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	1266259	USD
CY2013Q2	us-gaap	Sales Revenue Net SalesRevenueNet	1475416	USD
CY2012Q2	us-gaap	Sales Revenue Net SalesRevenueNet	3302624	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	2774029	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	4500995	USD
CY2013Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6941807	USD
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6657380	USD
CY2013Q2	us-gaap	Contract Receivable Retainage Due One Year Or Less ContractReceivableRetainageDueOneYearOrLess	848754	USD
CY2013Q2	us-gaap	Inventory Net InventoryNet	2642954	USD
CY2013Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	708723	USD
CY2013Q2	us-gaap	Assets Current AssetsCurrent	14823943	USD
CY2013Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	2262370	USD
CY2012Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	2216558	USD
CY2012Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	13263866	USD
CY2013Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10292829	USD
CY2012Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1380213	USD
CY2012Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	2240098	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1643127	USD
CY2012Q2	us-gaap	Cost Of Services CostOfServices	552768	USD
	us-gaap	Cost Of Services CostOfServices	289002	USD
	us-gaap	Cost Of Services CostOfServices	835277	USD
CY2013Q2	us-gaap	Cost Of Revenue CostOfRevenue	1044491	USD
CY2012Q2	us-gaap	Cost Of Revenue CostOfRevenue	2792866	USD
	us-gaap	Cost Of Revenue CostOfRevenue	1932129	USD
	us-gaap	Cost Of Revenue CostOfRevenue	3570706	USD
CY2013Q2	us-gaap	Gross Profit GrossProfit	430925	USD
CY2012Q2	us-gaap	Gross Profit GrossProfit	509758	USD
	us-gaap	Gross Profit GrossProfit	841900	USD
	us-gaap	Gross Profit GrossProfit	930289	USD
CY2013Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	29629	USD
CY2012Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	34420	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	61205	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	57858	USD
CY2013Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	227820	USD
CY2012Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	245755	USD
CY2012Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	3079139	USD
CY2012Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	431682	USD
CY2012Q4	nfec	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	1150948	USD
CY2013Q2	us-gaap	Liabilities Liabilities	13367583	USD
CY2013Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q2	us-gaap	Common Stock Value CommonStockValue	5459	USD
CY2013Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	9474623	USD
CY2013Q2	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	2212951	USD
CY2013Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	4301792	USD
CY2013Q2	us-gaap	Retained Earnings Unappropriated RetainedEarningsUnappropriated	15574445	USD
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	31569270	USD
CY2013Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	44936853	USD
CY2012Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	6016370	USD
CY2013Q2	us-gaap	Liabilities Current LiabilitiesCurrent	13367583	USD
CY2012Q2	us-gaap	Other Income OtherIncome	0	USD
	us-gaap	Other Income OtherIncome	36208	USD
CY2013Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	2568	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	374262	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	65217	USD
CY2012Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33708	USD
	us-gaap	Interest Expense InterestExpense	315718	USD
CY2013Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-107458	USD
CY2012Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-177021	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-176476	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-309045	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	682673	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	169018	USD
CY2013Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	553386	USD
CY2012Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	44916	USD
CY2012Q2	us-gaap	Operating Expenses OperatingExpenses	280175	USD
	us-gaap	Operating Expenses OperatingExpenses	570535	USD
	us-gaap	Operating Expenses OperatingExpenses	556027	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	173476	USD
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	229583	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	271365	USD
CY2013Q2	us-gaap	Other Income OtherIncome	5950	USD
	us-gaap	Other Income OtherIncome	0	USD
CY2012Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	6383	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	4548	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	6673	USD
CY2012Q2	us-gaap	Interest Expense InterestExpense	183404	USD
	us-gaap	Interest Expense InterestExpense	217232	USD
CY2013Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	66018	USD
CY2012Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	52562	USD
CY2013Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14001	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33107	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	52017	USD
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	18854	USD
	us-gaap	Net Income Loss NetIncomeLoss	61782	USD
	us-gaap	Net Income Loss NetIncomeLoss	18965	USD
CY2013Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	501369	USD
CY2012Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	26062	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	744455	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	187983	USD
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2012Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2012Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2013Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5459147	shares
CY2012Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5326501	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5419353	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5326501	shares
CY2013Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5459147	shares
CY2012Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5454501	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5419353	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5454501	shares
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	413720	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	382036	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	16629	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	0	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	94889	USD
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	93006	USD
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-293772	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	772635	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	32681	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-81837	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-49234	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	119066	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3723565	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1476334	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1133	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	270	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	156914	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
	us-gaap	Repayments Of Advances For Construction RepaymentsOfAdvancesForConstruction	940927	USD
	us-gaap	Repayments Of Advances For Construction RepaymentsOfAdvancesForConstruction	473640	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-785146	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-473910	USD
	us-gaap	Proceeds From Repayments Of Restricted Cash Financing Activities ProceedsFromRepaymentsOfRestrictedCashFinancingActivities	-1920633	USD
	us-gaap	Proceeds From Repayments Of Restricted Cash Financing Activities ProceedsFromRepaymentsOfRestrictedCashFinancingActivities	525492	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	0	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	34432	USD
	nfec	Adjustments To Additional Paid In Capital Interest Expense Related Party AdjustmentsToAdditionalPaidInCapitalInterestExpenseRelatedParty	16629	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	46252	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	28211	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1398971	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	292381	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-360446	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-264078	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4407729	USD
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	5681873	USD
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	2157932	USD
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	7278239	USD
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	4742708	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5117527	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-512813	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	42282	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	12475	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2136826	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	502086	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2317456	USD
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2819542	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	411	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	127603	USD
	us-gaap	Interest Paid InterestPaid	191228	USD
	us-gaap	Interest Paid InterestPaid	297020	USD
	us-gaap	Notes Issued1 NotesIssued1	3777245	USD
	us-gaap	Notes Issued1 NotesIssued1	1055411	USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	994836	USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1580903	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1600528	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
	us-gaap	Basis Of Accounting BasisOfAccounting	<table border="0" style="clear:both;width:100%; table-layout:fixed;"> <tr> <td></td> </tr> </table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; FONT-SIZE: 10pt"> <table style="clear:both;MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="TEXT-ALIGN: left; WIDTH: 0.9in"> <div><b>NOTE <font style="FONT-FAMILY: Times New Roman, Times, Serif">-</font> 1</b></div> </td> <td style="TEXT-ALIGN: justify"> <div><b>BASIS OF PRESENTATION</b></div> </td> </tr> </table> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The accompanying unaudited condensed consolidated financial statements have been prepared by management in accordance with both accounting principles generally accepted in the United States (“GAAP”), and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Certain information and note disclosures normally included in audited financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> In the opinion of management, the consolidated balance sheet as of December 31, 2012 which has been derived from audited financial statements and these unaudited condensed consolidated financial statements reflect all normal and recurring adjustments considered necessary to state fairly the results for the periods presented. The results for the period ended June 30, 2013 are not necessarily indicative of the results to be expected for the entire fiscal year ending December 31, 2013 or for any future period.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> These unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with the Management’s Discussion and the audited financial statements and notes thereto included in the Annual Report on Form 10-K for the year ended December 31, 2012.</div> </div>
	us-gaap	Nature Of Operations NatureOfOperations	<table border="0" style="clear:both;width:100%; table-layout:fixed;"> <tr> <td></td> </tr> </table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; FONT-SIZE: 10pt"> <table style="clear:both;MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="TEXT-ALIGN: left; WIDTH: 0.9in"> <div><strong>NOTE <font style="FONT-FAMILY: Times New Roman, Times, Serif">-</font> 2</strong></div> </td> <td style="TEXT-ALIGN: justify"> <div><strong>ORGANIZATION AND BUSINESS BACKGROUND</strong></div> </td> </tr> </table> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; TEXT-INDENT: -57.25pt; MARGIN: 0pt 0px 0pt 57.25pt; FONT: 10pt Times New Roman, Times, Serif"> <strong> </strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> NF Energy Saving Corporation (the “Company” or “NFEC”) was incorporated in the State of Delaware in the name of Galli Process, Inc. on October 31, 2000. On February 7, 2002, the Company changed its name to “Global Broadcast Group, Inc.” On November 12, 2004, the Company changed its name to “Diagnostic Corporation of America.” On March 15, 2007, the Company changed its name to “NF Energy Saving Corporation of America.” On August 24, 2009, the Company further changed its name to “NF Energy Saving Corporation.”</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The Company, through its subsidiaries, mainly engages in the production of heavy industrial components and products such as valves and the provision of technical service and re-engineering projects in the energy saving related industry in the People’s Republic of China (the “PRC”). All the customers are located in the PRC.</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <u>Description of subsidiaries</u></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; FONT-SIZE: 10pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="clear:both;BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="23%"> <div>Name</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="20%"> <div>Place of incorporation<br/> and kind of<br/> legal entity</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="26%"> <div>Principal activities<br/> and place of operation</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="15%" colspan="2"> <div>Particulars of<br/> issued/<br/> registered share<br/> capital</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Effective<br/> interest<br/> held</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="23%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="20%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="26%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="5%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="23%"> <div>Liaoning Nengfa Weiye Energy Technology Co. Ltd (“Nengfa Energy”)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="20%"> <div>The PRC, a limited liability company</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="26%"> <div>Production of a variety of industrial valve components which are widely used in water supply and sewage system, coal and gas fields, power generation stations, petroleum and chemical industries in the PRC</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="10%"> <div>US$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="5%"> <div>3,580,880</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="10%"> <div>100</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="23%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="20%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="26%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="5%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="10%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="23%"> <div>Liaoning Nengfa Weiye Tei Fa Sales Co., Ltd. (“Sales Company”)</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="20%"> <div>The PRC, a limited liability company</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="26%"> <div>Sales and marketing of valves components and products in the PRC</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="10%"> <div>RMB</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="5%"> <div>5,000,000</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="10%"> <div>99</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: top; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> </table> </div> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> NFEC and its subsidiaries are hereinafter referred to as (the “Company”).</div> </div>
CY2012Q4	us-gaap	Customer Deposits Current CustomerDepositsCurrent	316732	USD
CY2012Q4	nfec	Value Added Taxes Payable Current ValueAddedTaxesPayableCurrent	117360	USD
CY2012Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	200000	USD
CY2012Q4	nfec	Accrued Operating Expenses Current AccruedOperatingExpensesCurrent	193177	USD
CY2012Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	76295	USD
	nfec	Income Before Income Taxes IncomeBeforeIncomeTaxes	120384	USD
	nfec	Income Before Income Taxes IncomeBeforeIncomeTaxes	107482	USD
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	26871	USD
	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	19381	USD
	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	0	USD
	us-gaap	Use Of Estimates UseOfEstimates	<table border="0" style="clear:both;width:100%; table-layout:fixed;"> <tr> <td></td> </tr> </table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; FONT-SIZE: 10pt"> <table style="clear:both;MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0px"></td> <td style="WIDTH: 27pt"> <div><font style="FONT-FAMILY: Symbol">⋅</font></div> </td> <td style="TEXT-ALIGN: justify"> <div>Use of estimates</div> </td> </tr> </table> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif">  </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> In preparing these condensed consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheet and revenues and expenses during the periods reported. Actual results may differ from these estimates.</div> </div>
CY2012Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0653	pure
	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	10400000	CNY
CY2013Q2	us-gaap	Depreciation Depreciation	195130	USD
CY2012Q2	us-gaap	Depreciation Depreciation	195941	USD
	us-gaap	Depreciation Depreciation	380693	USD
	us-gaap	Depreciation Depreciation	349414	USD
	nfec	Value Added Tax Rate ValueAddedTaxRate	0.17	pure
CY2013Q2	nfec	Percentage Of Income Tax Examination Minimum Likelihood Of Tax Benefits Being Realized Upon Settlement PercentageOfIncomeTaxExaminationMinimumLikelihoodOfTaxBenefitsBeingRealizedUponSettlement	0.5	pure
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	66691	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	66691	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	66691	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	66691	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	66691	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	2767687	USD
CY2013Q2	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	6.1882	pure
CY2012Q2	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	6.3197	pure
	nfec	Weighted Average Exchange Rate WeightedAverageExchangeRate	6.2479	pure
	nfec	Weighted Average Exchange Rate WeightedAverageExchangeRate	6.3255	pure
CY2013Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1068442	USD
CY2012Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	576988	USD
CY2013Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1574512	USD
CY2012Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	628572	USD
CY2008	nfec	Estimated Construction Cost EstimatedConstructionCost	24000000	USD
CY2013Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.06	pure
	nfec	Percentage For Maintaing Cash Deposit With Banks PercentageForMaintaingCashDepositWithBanks	0.5	pure
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	7.93
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	0
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	7.93
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2013Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	211743	USD
CY2013Q2	nfec	Expenditures For Long Lived Assets ExpendituresForLongLivedAssets	723100	USD
	nfec	Expenditures For Long Lived Assets ExpendituresForLongLivedAssets	942060	USD
CY2013Q2	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	1500000	USD
CY2012Q4	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	3079139	USD
CY2013Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	221047	USD
CY2012Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	247384	USD
CY2013Q2	us-gaap	Customer Deposits Current CustomerDepositsCurrent	288095	USD
CY2013Q2	nfec	Value Added Taxes Payable Current ValueAddedTaxesPayableCurrent	3727	USD
CY2013Q2	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	200000	USD
CY2013Q2	nfec	Accrued Operating Expenses Current AccruedOperatingExpensesCurrent	161414	USD
CY2013Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	177690	USD
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	30096	USD
	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	41230	USD
	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	38219	USD
CY2013Q1	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	132646	shares
CY2013Q1	us-gaap	Share Price SharePrice	7.50
CY2013Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	994836	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	23334	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0	shares
	nfec	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercises In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriod	0	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	23334	shares
CY2012Q4	nfec	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercise Price Ranges ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisePriceRanges	4.50
	nfec	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grant In Period Exercise Price Range ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantInPeriodExercisePriceRange	0
	nfec	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Canceled In Period Exercise Price Range ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCanceledInPeriodExercisePriceRange	0
	nfec	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Exercise Price Range ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodExercisePriceRange	0
CY2013Q2	nfec	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercise Price Ranges ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisePriceRanges	4.50
CY2012Q4	nfec	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice	4.50
	nfec	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	nfec	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Canceled In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsCanceledInPeriodWeightedAverageExercisePrice	0
	nfec	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2013Q2	nfec	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageExercisePrice	4.50
CY2012Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	212238	USD
CY2012Q2	nfec	Expenditures For Long Lived Assets ExpendituresForLongLivedAssets	467837	USD
CY2012Q2	us-gaap	Assets Assets	43899083	USD
	nfec	Expenditures For Long Lived Assets ExpendituresForLongLivedAssets	473910	USD
CY2013Q2	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	0.93	pure
	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	0.75	pure
	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	1680000	USD

Files In Submission

Name	View Source	Status
0001144204-13-045501-index-headers.html	Edgar Link	pending
0001144204-13-045501-index.html	Edgar Link	pending
0001144204-13-045501.txt	Edgar Link	pending
0001144204-13-045501-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
nfec-20130630.xml	Edgar Link	completed
nfec-20130630.xsd	Edgar Link	pending
nfec-20130630_cal.xml	Edgar Link	unprocessable
nfec-20130630_def.xml	Edgar Link	unprocessable
nfec-20130630_lab.xml	Edgar Link	unprocessable
nfec-20130630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R1.xml	Edgar Link	unprocessable
R10.htm	Edgar Link	pending
R10.xml	Edgar Link	unprocessable
R11.htm	Edgar Link	pending
R11.xml	Edgar Link	unprocessable
R12.htm	Edgar Link	pending
R12.xml	Edgar Link	unprocessable
R13.htm	Edgar Link	pending
R13.xml	Edgar Link	unprocessable
R14.htm	Edgar Link	pending
R14.xml	Edgar Link	unprocessable
R15.htm	Edgar Link	pending
R15.xml	Edgar Link	unprocessable
R16.htm	Edgar Link	pending
R16.xml	Edgar Link	unprocessable
R17.htm	Edgar Link	pending
R17.xml	Edgar Link	unprocessable
R18.htm	Edgar Link	pending
R18.xml	Edgar Link	unprocessable
R19.htm	Edgar Link	pending
R19.xml	Edgar Link	unprocessable
R2.htm	Edgar Link	pending
R2.xml	Edgar Link	unprocessable
R20.htm	Edgar Link	pending
R20.xml	Edgar Link	unprocessable
R21.htm	Edgar Link	pending
R21.xml	Edgar Link	unprocessable
R22.htm	Edgar Link	pending
R22.xml	Edgar Link	unprocessable
R23.htm	Edgar Link	pending
R23.xml	Edgar Link	unprocessable
R24.htm	Edgar Link	pending
R24.xml	Edgar Link	unprocessable
R25.htm	Edgar Link	pending
R25.xml	Edgar Link	unprocessable
R26.htm	Edgar Link	pending
R26.xml	Edgar Link	unprocessable
R27.htm	Edgar Link	pending
R27.xml	Edgar Link	unprocessable
R28.htm	Edgar Link	pending
R28.xml	Edgar Link	unprocessable
R29.htm	Edgar Link	pending
R29.xml	Edgar Link	unprocessable
R3.htm	Edgar Link	pending
R3.xml	Edgar Link	unprocessable
R30.htm	Edgar Link	pending
R30.xml	Edgar Link	unprocessable
R31.htm	Edgar Link	pending
R31.xml	Edgar Link	unprocessable
R32.htm	Edgar Link	pending
R32.xml	Edgar Link	unprocessable
R33.htm	Edgar Link	pending
R33.xml	Edgar Link	unprocessable
R34.htm	Edgar Link	pending
R34.xml	Edgar Link	unprocessable
R35.htm	Edgar Link	pending
R35.xml	Edgar Link	unprocessable
R36.htm	Edgar Link	pending
R36.xml	Edgar Link	unprocessable
R37.htm	Edgar Link	pending
R37.xml	Edgar Link	unprocessable
R38.htm	Edgar Link	pending
R38.xml	Edgar Link	unprocessable
R39.htm	Edgar Link	pending
R39.xml	Edgar Link	unprocessable
R4.htm	Edgar Link	pending
R4.xml	Edgar Link	unprocessable
R40.htm	Edgar Link	pending
R40.xml	Edgar Link	unprocessable
R41.htm	Edgar Link	pending
R41.xml	Edgar Link	unprocessable
R42.htm	Edgar Link	pending
R42.xml	Edgar Link	unprocessable
R43.htm	Edgar Link	pending
R43.xml	Edgar Link	unprocessable
R44.htm	Edgar Link	pending
R44.xml	Edgar Link	unprocessable
R45.htm	Edgar Link	pending
R45.xml	Edgar Link	unprocessable
R46.htm	Edgar Link	pending
R46.xml	Edgar Link	unprocessable
R47.htm	Edgar Link	pending
R47.xml	Edgar Link	unprocessable
R48.htm	Edgar Link	pending
R48.xml	Edgar Link	unprocessable
R49.htm	Edgar Link	pending
R49.xml	Edgar Link	unprocessable
R5.htm	Edgar Link	pending
R5.xml	Edgar Link	unprocessable
R50.htm	Edgar Link	pending
R50.xml	Edgar Link	unprocessable
R51.htm	Edgar Link	pending
R51.xml	Edgar Link	unprocessable
R52.htm	Edgar Link	pending
R52.xml	Edgar Link	unprocessable
R53.htm	Edgar Link	pending
R53.xml	Edgar Link	unprocessable
R54.htm	Edgar Link	pending
R54.xml	Edgar Link	unprocessable
R55.htm	Edgar Link	pending
R55.xml	Edgar Link	unprocessable
R56.htm	Edgar Link	pending
R56.xml	Edgar Link	unprocessable
R6.htm	Edgar Link	pending
R6.xml	Edgar Link	unprocessable
R7.htm	Edgar Link	pending
R7.xml	Edgar Link	unprocessable
R8.htm	Edgar Link	pending
R8.xml	Edgar Link	unprocessable
R9.htm	Edgar Link	pending
R9.xml	Edgar Link	unprocessable
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v352631_10q.htm	Edgar Link	pending
v352631_ex31-1.htm	Edgar Link	pending
v352631_ex31-2.htm	Edgar Link	pending
v352631_ex32-1.htm	Edgar Link	pending
v352631_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BIMI
BIMI Holdings Inc. Stock $bimi

2013 Q2 Form 10-Q Financial Statement

#000114420413045501 Filed on August 14, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BIMI BIMI Holdings Inc. Stock $bimi

2013 Q2 Form 10-Q Financial Statement

#000114420413045501 Filed on August 14, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BIMI
BIMI Holdings Inc. Stock $bimi